We Measure Everything We Do

Just as patients deserve medications that have been proven to work, so do communities deserve health systems that have proven efficacy. For Muso, rigorous measurement is our moral responsibility. Traditional healthcare systems measure their impact based on how they treat patients who walk through the door. For Muso, health systems should care as much about the patients who never make it to the door. We test our impact at a population level, to assess how the health of entire communities changes. We do this by conducting rigorous scientific studies with academic partners.

Learning in Real Time

In addition to conducting rigorous population research, we’ve built data feedback loops that help us iterate on our design and provide better care for our patients every day. We do this by analyzing data that community health workers, doctors, and other providers collect daily as they care for patients.
5,375,479Cumulative Home Visits

97Percent of Patients Treated Within 72 Hours

599,712Cumulative Clinic Visits

Child Mortality Study

A study published in BMJ Global Health evaluated rapid access to care and child mortality before and after the roll-out of ProCCM in a peri-urban area of Mali by Muso and the Malian Ministry of Health. When the study began in 2008, this are had one of the world's highest rates of child mortality: 1 in 7 children died before they could celebrate their fifth birthday. Seven years later, child deaths had become rare—only 1 in 142 children. These communities achieved a child mortality rate of 7 deaths per 1,000 live births, a rate comparable to the United States.


Before and After ProCCM Intervention

Under-five mortality rates before and during the ProCCM intervention, in the area of the intervention (blue circles), in urban areas of Mali (black circles) and nationally in Mali (black line).

Early Treatment Doubled

The percentage of children starting effective malaria treatment within 24 hours of symptom onset increased from 14% to 35%.

Healthier Children

The percentage of children sick with a fever was approximately cut in half.

Study Limitations

First, there was no control group, so no causal conclusions could be drawn.
Second, the study tested the entire intervention as an integrated unit, and therefore could not draw conclusions on the relative contributions of each element of the intervention.


Follow-On Studies

Building from this foundational research, we are currently pursuing follow-on studies together with partners and collaborators from academic institutions around the world.